在中介开发直角选择性mAb下游工艺,以去除与工艺相关的杂质

Dongyoun Jang1, Mario A Gutierrez-Diaz1, Scott H Altern1

  • 1Department of Chemical and Biological Engineering and Center for Biotechnology and Interdisciplinary Studies, Rensselaer Polytechnic Institute, Troy, New York, USA.

Biotechnology progress
|December 16, 2025
PubMed
概括

这项研究提出了一个in silico工作流程,用于开发快速的非蛋白质A净化过程,以从单克隆抗体 (mAb) 治疗中去除宿主细胞蛋白 (HCP),显著减少净化步骤并提高效率.